Business Description
Accendra Health Inc
NAICS : 423450
SIC : 5047
ISIN : US6907321029
Share Class Description:
ACH: Ordinary SharesTotal Employee Number:
6,500Compare
Compare
Traded in other countries / regions
ACH.USA6OM.Germany Index Membership
Russell 2000Russell 3000 IPO Date
1973-01-02Description
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.16 | |||||
Equity-to-Asset | -0.19 | |||||
Debt-to-Equity | -4.67 | |||||
Debt-to-EBITDA | 9.2 | |||||
Interest Coverage | 1.63 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.25 | |||||
Beneish M-Score | -4.62 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -35 | |||||
3-Year EBITDA Growth Rate | -16.1 | |||||
3-Year EPS without NRI Growth Rate | -25.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 9.37 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 3.5 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 51.55 | |||||
9-Day RSI | 53.86 | |||||
14-Day RSI | 54.48 | |||||
3-1 Month Momentum % | 8.47 | |||||
6-1 Month Momentum % | 32.67 | |||||
12-1 Month Momentum % | -58.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.49 | |||||
Quick Ratio | 0.43 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 83.62 | |||||
Days Sales Outstanding | 29.89 | |||||
Days Payable | 140.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 23.31 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 45.95 | |||||
Operating Margin % | 6.91 | |||||
Net Margin % | -39.84 | |||||
EBITDA Margin % | 8.69 | |||||
FCF Margin % | -11.51 | |||||
OCF Margin % | -4.3 | |||||
ROA % | -30.2 | |||||
ROIC % | 5.32 | |||||
3-Year ROIIC % | 3.32 | |||||
ROC (Joel Greenblatt) % | 0.49 | |||||
ROCE % | 0.15 | |||||
Years of Profitability over Past 10-Year | 5 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 3.47 | |||||
PE Ratio without NRI | 4.96 | |||||
PS Ratio | 0.1 | |||||
EV-to-EBIT | 831.42 | |||||
EV-to-Forward-EBIT | 9.27 | |||||
EV-to-EBITDA | 8.87 | |||||
EV-to-Forward-EBITDA | 5.46 | |||||
EV-to-Revenue | 0.77 | |||||
EV-to-Forward-Revenue | 0.75 | |||||
EV-to-FCF | -6.69 | |||||
Price-to-GF-Value | 0.62 | |||||
Price-to-Projected-FCF | 0.61 | |||||
Price-to-Median-PS-Value | 0.61 | |||||
Earnings Yield (Greenblatt) % | 0.12 | |||||
FCF Yield % | -121.08 | |||||
Forward Rate of Return (Yacktman) % | 33.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:ACH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Accendra Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2,715.928 | ||
| EPS (TTM) ($) | -14.05 | ||
| Beta | 2.4609 | ||
| 3-Year Sharpe Ratio | -0.47 | ||
| 3-Year Sortino Ratio | -0.68 | ||
| Volatility % | 92.9 | ||
| 14-Day RSI | 54.48 | ||
| 14-Day ATR ($) | 0.246363 | ||
| 20-Day SMA ($) | 3.301 | ||
| 12-1 Month Momentum % | -58.99 | ||
| 52-Week Range ($) | 1.84 - 8.4 | ||
| Shares Outstanding (Mil) | 76.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Accendra Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Accendra Health Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-30 17:00 | In 109 days | ||
| Third quarter earnings results for 2026 | 2026-10-30 | In 108 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-11 08:30 | In 29 days | ||
| Second quarter earnings results for 2026 | 2026-08-11 | In 28 days | ||
| General meeting for 2026 | 2026-05-14 09:00 | 3.15 (-1.56%) | ||
| First quarter earnings conference call for 2026 | 2026-05-11 08:30 | 3.58 (-3.76%) | ||
| First quarter earnings results for 2026 | 2026-05-11 | 3.58 (-3.76%) | ||
| Annual report for 2025 | 2026-02-20 | 2.48 (+2.48%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-19 17:00 | 2.41 (+3.88%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-19 | 2.41 (+3.88%) |
Show
Entries
Accendra Health Inc Frequently Asked Questions
What is Accendra Health Inc(ACH)'s stock price today?
The current price of ACH is $3.37. The 52 week high of ACH is $8.40 and 52 week low is $1.84.
When is next earnings date of Accendra Health Inc(ACH)?
The next earnings date of Accendra Health Inc(ACH) is .
Does Accendra Health Inc(ACH) pay dividends? If so, how much?
Accendra Health Inc(ACH) does not pay dividend.
Guru Commentaries on NYSE:ACH
No articles.
Press Release
Articles on Accendra Health Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers